BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.

Saved in:
Bibliographic Details
Title: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
Authors: Fischer DL; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI, 49503-2532, USA., Auinger P; Center for Health and Technology, Department of Neurology, University of Rochester, Rochester, NY, USA., Goudreau JL; Department of Neurology and Ophthalmology, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, USA., Cole-Strauss A; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI, 49503-2532, USA., Kieburtz K; Center for Health and Technology, Department of Neurology, University of Rochester, Rochester, NY, USA., Elm JJ; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA., Hacker ML; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Charles PD; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Lipton JW; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI, 49503-2532, USA.; Hauenstein Neuroscience Center, Mercy Health Saint Mary's, Grand Rapids, MI, USA., Pickut BA; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI, 49503-2532, USA.; Hauenstein Neuroscience Center, Mercy Health Saint Mary's, Grand Rapids, MI, USA., Sortwell CE; Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI, 49503-2532, USA. sortwell@msu.edu.; Hauenstein Neuroscience Center, Mercy Health Saint Mary's, Grand Rapids, MI, USA. sortwell@msu.edu.
Source: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2020 Oct; Vol. 17 (4), pp. 1785-1795. Date of Electronic Publication: 2020 Nov 19.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-7479
DOI:10.1007/s13311-020-00965-9